ADC

198개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved198 programs
ADCStandard DatabasestaleDaiichi Sankyo Co., Ltd.Phase 2

Fixed dose (Patritumab Deruxtecan, Patritumab Deruxtecan (Fixed dose))

Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor · Non-Small Cell Lung Cancer Metastatic

#Non-SmallCellLungCancerMetastati#ADC#Phase2#Popular#antibody-drug-conjugate+3
Trials 149Status Recruiting
ADCStandard DatabasestaleDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Approved

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201)

Colorectal Cancer; Resectable Colorectal Carcinoma · Metastatic Salivary Gland Carcinoma

#MetastaticSalivaryGlandCarcinoma#ADC#Approved#Popular#antibody-drug-conjugate+5
Trials 149Status Recruiting
ADCStandard DatabasestaleDaiichi Sankyo Co., Ltd.deruxtecan, sacituzumab gov…Phase 2

Up-Titration (Patritumab Deruxtecan, Patritumab Deruxtecan (Up-Titration))

Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor · Non-Small Cell Lung Cancer Metastatic

#Non-SmallCellLungCancerMetastati#ADC#Phase2#Popular#antibody-drug-conjugate+4
Trials 148Status Recruiting
ADCStandard DatabasestaleDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzumab Deruxtecan (T-DXd) monotherapy)

Gastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#ADC#Phase2#Popular#antibody-drug-conjugate+4
Trials 134Status Recruiting
ADCLimited DatastaleRochederuxtecan (Dato-DXd, Datro…Phase 3

T-DXd (Trastuzumab-Deruxtecan, Trastuzumab-Deruxtecan (T-DXd))

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#Popular#antibody-drug-conjugate+3
Trials 134Status Recruiting
ADCStandard DatabasestaleRocheDM1 via butelase-1 with ABD…Approved

trastuzumab (Herceptin, Trastuzumab Emtansine)

Metastatic Breast Cancer · Metastatic Salivary Gland Carcinoma

#MetastaticSalivaryGlandCarcinoma#ADC#Approved#Popular#antibody-drug-conjugate+4
Trials 127Status Discontinued
ADCStandard DatabasestaleDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 3

DS-8201a (Trastuzumab deruxtecan, Trastuzumab deruxtecan (DS-8201a))

Breast Cancer; Non-small Cell Lung Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase3#Popular#antibody-drug-conjugate+4
Trials 124Status Recruiting
ADCLimited DatastaleDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Approved

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzumab deruxtecan (T-DXd) with pyrotinib)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Approved#Popular#antibody-drug-conjugate+3
Trials 124Status Recruiting
ADCStandard DatabasestaleDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 2

T-DXd, DS-8201a (Trastuzumab deruxtecan, Trastuzumab deruxtecan (T-DXd, DS-8201a))

Advanced Breast Cancer; Advanced Breast Carcinoma · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase2#Popular#antibody-drug-conjugate+4
Trials 122Status Recruiting
ADCStandard DatabasestaleSeagenVedotin: A Retrospective Co…Phase 2

BV (Induction with Brentuximab vedotin, Induction with Brentuximab vedotin (BV))

Hodgkin Lymphoma, Adult · Hodgkin Lymphoma, Adult

#HodgkinLymphomaAdult#ADC#Phase2#Popular#antibody-drug-conjugate+5
Trials 119Status Recruiting
ADCLimited DatastaleSeagenvedotin and the anti-HER2 t…Preclinical

Genetical Recombination (Brentuximab Vedotin, Brentuximab Vedotin (Genetical Recombination))

Untreated CD30-Positive Hodgkin's Lymphoma · Peripheral T Cell Lymphoma

#PeripheralTCellLymphoma#ADC#Preclinical#Popular#antibody-drug-conjugate+4
Trials 93Status Active
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin(RC48) Plus Tratuzumab)

HER2-positive Gastric Cancer; HER2-positive Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#Popular#antibody-drug-conjugate+4
Trials 91Status Recruiting
ADCStandard DatabasestaleRocheDM1 via butelase-1 with ABD…Phase 2

trastuzumab (Herceptin, Ado-trastuzumab, Ado-trastuzumab (T) emtansine (T-DM1))

Salivary Gland Cancer; HER2 Gene Mutation · HER2

#HER2#ADC#Phase2#Popular#antibody-drug-conjugate+5
Trials 85Status Recruiting
ADCLimited DatastaleShanghai Fosun Pharmaceutical I…DM1 via butelase-1 with ABD…Phase 3

Kadcyla, T-DM1 (Control drug: Trastuzumab emtansine, Control drug: Trastuzumab emtansine (Kadcyla, T-DM1))

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#Popular#antibody-drug-conjugate+3
Trials 84Status Active
ADCStandard DatabasestalePfizerPhase 2

Gemtuzumab Ozogamicin (Gemtuzumab Ozogamicin)

Acute Myelogenous Leukemia; Myelodysplastic Syndrome · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#ADC#Phase2#Popular#antibody-drug-conjugate+4
Trials 78Status Recruiting
ADCStandard DatabasestaleGSKcys-mcMMAFPhase 3

belantamab mafodotin (Blenrep, GSK2857916)

Primary Immune Thrombocytopenia (ITP) · Multiple Myeloma

#MultipleMyeloma#ADC#Phase3#Popular#antibody-drug-conjugate+4
Trials 73Status Recruiting
ADCCurated CorestaleSuzhou Suncadia Biopharmaceutic…rezetecanPhase 3

SHR-A1811 (SHR-A1811)

Gastric Cancer; HER2 + Gastric Cancer · HER2

#HER2#ADC#Phase3#BioJungboMoa-pick#Popular+5
Trials 62Status Recruiting
ADCLimited DatastaleMerck Sharp & Dohme LLCGovitecan in gynecologic ma…Phase 2

sac-TMT (Sacituzumab Tirumotecan, Sacituzumab Tirumotecan (sac-TMT))

Gastroesophageal Junction; Gastroesophageal Adenocarcinoma · Gastroesophageal Junction

#GastroesophagealJunction#ADC#Phase2#Popular#antibody-drug-conjugate+4
Trials 62Status Recruiting
ADCLimited DatastaleRocheDM1 via butelase-1 with ABD…Phase 3

T-DM1 (Ado-trastuzumab emtansine, Ado-trastuzumab emtansine (T-DM1))

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#Popular#antibody-drug-conjugate+3
Trials 61Status Recruiting
ADCLimited DatastaleCelldex TherapeuticsPhase 2

nivolumab OR pembrolizumab (glembatumumab vedotin and PD-1 targeted checkpoint inhibitor, glembatumumab vedotin and PD-1 targeted checkpoint inhibitor (nivolumab OR pembrolizumab))

Melanoma · PD-1

#PD-1#ADC#Phase2#Popular#antibody-drug-conjugate+3
Trials 60Status Discontinued

2 / 10 pages

← PreviousNext →